Salarius Pharmaceuticals

-$0.0349 (-3.71%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.

About SLRX

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.

CEO
David J. Arthur
Employees
9
Headquarters
Houston, Texas
Founded
2014

SLRX Key Statistics

Market Cap
40.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.07K
High Today
$0.935
Low Today
$0.9023
Open Price
$0.92
Volume
298.25K
52 Week High
$3.50
52 Week Low
$0.632

SLRX Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure